NCT07136467

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,795 (estimated)
• Sponsor: AbbVie · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.

Conditions

• Non-Segmental Vitiligo (NSV)
• Alopecia Areata
• Hidradenitis Suppurativa

Timeline

• Start date: 2025-09-02
• Primary completion: 2027-08-01
• Completion: 2027-08-01
• First posted: 2025-08-22
• Last updated: 2026-02-13

Locations

116 sites across 18 countries: Argentina, Canada, Colombia, Czechia, Estonia, France, Germany, Greece, Italy, Japan, Latvia, Puerto Rico, Romania, South Korea, Spain, Switzerland, Taiwan, United Kingdom